The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe.

Mori, Hideki; Schol, Jolien; Geeraerts, Annelies; Huang, I-Hsuan; Jandee, Sawangpong; Gonlachanvit, Sutep; Tseng, Ping-Huei; Lu, Ching-Liang; Kamiya, Takeshi; Kim, Nayoung; Lee, Yeong Yeh; Kuribayashi, Shiko; Tack, Jan; Suzuki, Hidekazu
Journal of clinical medicine
2020Oct ; 9 ( 10 ) :.
ÀúÀÚ »ó¼¼Á¤º¸
Mori, Hideki -
Schol, Jolien -
Geeraerts, Annelies -
Huang, I-Hsuan -
Jandee, Sawangpong -
Gonlachanvit, Sutep -
Tseng, Ping-Huei -
Lu, Ching-Liang -
Kamiya, Takeshi -
Kim, Nayoung -
Lee, Yeong Yeh -
Kuribayashi, Shiko -
Tack, Jan -
Suzuki, Hidekazu -
ABSTRACT
BACKGROUND: The new coronavirus disease (COVID-19) has high infection and mortality rates, and has become a pandemic. The infection and mortality rates are lower in Asian countries than in European countries. This study aimed to conduct a survey on the effects of COVID-19 on the capacity to perform gastrointestinal motility tests in Asian countries compared with European countries.

METHODS: We used the questionnaire previously established by our team for researchers in European countries. The correlation between the decreased rate of gastrointestinal motility and function tests, and the infection/mortality rates of COVID-19 and stringency of a government's interventions in each country was analysed and protective measures were assessed.

RESULTS: In total, 58 gastroenterologists/motility experts in Asian countries responded to this survey. The infection/mortality rates of COVID-19 and Stringency Index had a significant impact on the testing capacity of oesophageal manometry and catheter-based pH monitoring. In European countries, most facilities used filtering facepiece 2/3 (FFP2/3) masks during oesophageal motility studies. Meanwhile, in Asian countries, most facilities used surgical masks. CONCLUSION: The total infection and mortality rates of COVID-19 can affect the rate of gastrointestinal motility testing and the type of protective equipment that must be used.
keyword
COVID-19; SARS-CoV-2; anorectal manometry; breath tests; catheter-based pH-monitoring; infection prevention; motility disorders of the gastrointestinal tract; oesophageal manometry; wireless pH-monitoring (Bravo¢ç)
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
The total infection and mortality rates of COVID-19 can affect the rate of gastrointestinal motility testing and the type of protective equipment that must be used.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.3390/jcm9103189
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå